John Kipritidis1,2, Bilal A Tahir3,4, Guillaume Cazoulat5, Michael S Hofman6, Shankar Siva6, Jason Callahan6, Nicholas Hardcastle6, Tokihiro Yamamoto7, Gary E Christensen8, Joseph M Reinhardt8, Noriyuki Kadoya9, Taylor J Patton10, Sarah E Gerard8, Isabella Duarte11, Ben Archibald-Heeren12,13, Mikel Byrne12, Rick Sims14, Scott Ramsay14, Jeremy T Booth1,15, Enid Eslick1,2, Fiona Hegi-Johnson2,6, Henry C Woodruff16, Rob H Ireland3, Jim M Wild4, Jing Cai11,17, John E Bayouth10, Kristy Brock5, Paul J Keall2. 1. Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, NSW, Australia. 2. Sydney Medical School, University of Sydney, Sydney, NSW, Australia. 3. Academic Unit of Clinical Oncology, University of Sheffield, Sheffield, UK. 4. Academic Radiology, POLARIS, University of Sheffield, Sheffield, UK. 5. The University of Texas MD Anderson Cancer Center, Department of Imaging Physics, Houston, TX, USA. 6. Peter MacCallum Cancer Centre, Melbourne, Vic., Australia. 7. University of California Davis School of Medicine, Sacramento, CA, USA. 8. University of Iowa, Iowa City, IA, USA. 9. Tohoku University Graduate School of Medicine, Sendai, Japan. 10. University of Wisconsin-Madison, Madison, WI, USA. 11. Duke University Medical Center, Durham, NC, USA. 12. Radiation Oncology Centres, Sydney Adventist Hospital, Sydney, NSW, Australia. 13. University of Wollongong, Wollongong, NSW, Australia. 14. Auckland Radiation Oncology, Auckland, New Zealand. 15. School of Physics, University of Sydney, Sydney, NSW, Australia. 16. The D-Lab: Decision Support for Precision Medicine, GROW - School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands. 17. Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong.
Abstract
PURPOSE: CT ventilation imaging (CTVI) is being used to achieve functional avoidance lung cancer radiation therapy in three clinical trials (NCT02528942, NCT02308709, NCT02843568). To address the need for common CTVI validation tools, we have built the Ventilation And Medical Pulmonary Image Registration Evaluation (VAMPIRE) Dataset, and present the results of the first VAMPIRE Challenge to compare relative ventilation distributions between different CTVI algorithms and other established ventilation imaging modalities. METHODS: The VAMPIRE Dataset includes 50 pairs of 4DCT scans and corresponding clinical or experimental ventilation scans, referred to as reference ventilation images (RefVIs). The dataset includes 25 humans imaged with Galligas 4DPET/CT, 21 humans imaged with DTPA-SPECT, and 4 sheep imaged with Xenon-CT. For the VAMPIRE Challenge, 16 subjects were allocated to a training group (with RefVI provided) and 34 subjects were allocated to a validation group (with RefVI blinded). Seven research groups downloaded the Challenge dataset and uploaded CTVIs based on deformable image registration (DIR) between the 4DCT inhale/exhale phases. Participants used DIR methods broadly classified into B-splines, Free-form, Diffeomorphisms, or Biomechanical modeling, with CT ventilation metrics based on the DIR evaluation of volume change, Hounsfield Unit change, or various hybrid approaches. All CTVIs were evaluated against the corresponding RefVI using the voxel-wise Spearman coefficient r S , and Dice similarity coefficients evaluated for low function lung ( DSC low ) and high function lung ( DSC high ). RESULTS: A total of 37 unique combinations of DIR method and CT ventilation metric were either submitted by participants directly or derived from participant-submitted DIR motion fields using the in-house software, VESPIR. The r S and DSC results reveal a high degree of inter-algorithm and intersubject variability among the validation subjects, with algorithm rankings changing by up to ten positions depending on the choice of evaluation metric. The algorithm with the highest overall cross-modality correlations used a biomechanical model-based DIR with a hybrid ventilation metric, achieving a median (range) of 0.49 (0.27-0.73) for r S , 0.52 (0.36-0.67) for DSC low , and 0.45 (0.28-0.62) for DSC high . All other algorithms exhibited at least one negative r S value, and/or one DSC value less than 0.5. CONCLUSIONS: The VAMPIRE Challenge results demonstrate that the cross-modality correlation between CTVIs and the RefVIs varies not only with the choice of CTVI algorithm but also with the choice of RefVI modality, imaging subject, and the evaluation metric used to compare relative ventilation distributions. This variability may arise from the fact that each of the different CTVI algorithms and RefVI modalities provides a distinct physiologic measurement. Ultimately this variability, coupled with the lack of a "gold standard," highlights the ongoing importance of further validation studies before CTVI can be widely translated from academic centers to the clinic. It is hoped that the information gleaned from the VAMPIRE Challenge can help inform future validation efforts.
PURPOSE:CT ventilation imaging (CTVI) is being used to achieve functional avoidance lung cancer radiation therapy in three clinical trials (NCT02528942, NCT02308709, NCT02843568). To address the need for common CTVI validation tools, we have built the Ventilation And Medical Pulmonary Image Registration Evaluation (VAMPIRE) Dataset, and present the results of the first VAMPIRE Challenge to compare relative ventilation distributions between different CTVI algorithms and other established ventilation imaging modalities. METHODS: The VAMPIRE Dataset includes 50 pairs of 4DCT scans and corresponding clinical or experimental ventilation scans, referred to as reference ventilation images (RefVIs). The dataset includes 25 humans imaged with Galligas 4DPET/CT, 21 humans imaged with DTPA-SPECT, and 4 sheep imaged with Xenon-CT. For the VAMPIRE Challenge, 16 subjects were allocated to a training group (with RefVI provided) and 34 subjects were allocated to a validation group (with RefVI blinded). Seven research groups downloaded the Challenge dataset and uploaded CTVIs based on deformable image registration (DIR) between the 4DCT inhale/exhale phases. Participants used DIR methods broadly classified into B-splines, Free-form, Diffeomorphisms, or Biomechanical modeling, with CT ventilation metrics based on the DIR evaluation of volume change, Hounsfield Unit change, or various hybrid approaches. All CTVIs were evaluated against the corresponding RefVI using the voxel-wise Spearman coefficient r S , and Dice similarity coefficients evaluated for low function lung ( DSC low ) and high function lung ( DSC high ). RESULTS: A total of 37 unique combinations of DIR method and CT ventilation metric were either submitted by participants directly or derived from participant-submitted DIR motion fields using the in-house software, VESPIR. The r S and DSC results reveal a high degree of inter-algorithm and intersubject variability among the validation subjects, with algorithm rankings changing by up to ten positions depending on the choice of evaluation metric. The algorithm with the highest overall cross-modality correlations used a biomechanical model-based DIR with a hybrid ventilation metric, achieving a median (range) of 0.49 (0.27-0.73) for r S , 0.52 (0.36-0.67) for DSC low , and 0.45 (0.28-0.62) for DSC high . All other algorithms exhibited at least one negative r S value, and/or one DSC value less than 0.5. CONCLUSIONS: The VAMPIRE Challenge results demonstrate that the cross-modality correlation between CTVIs and the RefVIs varies not only with the choice of CTVI algorithm but also with the choice of RefVI modality, imaging subject, and the evaluation metric used to compare relative ventilation distributions. This variability may arise from the fact that each of the different CTVI algorithms and RefVI modalities provides a distinct physiologic measurement. Ultimately this variability, coupled with the lack of a "gold standard," highlights the ongoing importance of further validation studies before CTVI can be widely translated from academic centers to the clinic. It is hoped that the information gleaned from the VAMPIRE Challenge can help inform future validation efforts.
Authors: Kai Ding; Kunlin Cao; Matthew K Fuld; Kaifang Du; Gary E Christensen; Eric A Hoffman; Joseph M Reinhardt Journal: Med Phys Date: 2012-08 Impact factor: 4.071
Authors: Joseph M Reinhardt; Kai Ding; Kunlin Cao; Gary E Christensen; Eric A Hoffman; Shalmali V Bodas Journal: Med Image Anal Date: 2008-04-12 Impact factor: 8.545
Authors: Keelin Murphy; Bram van Ginneken; Joseph M Reinhardt; Sven Kabus; Kai Ding; Xiang Deng; Kunlin Cao; Kaifang Du; Gary E Christensen; Vincent Garcia; Tom Vercauteren; Nicholas Ayache; Olivier Commowick; Grégoire Malandain; Ben Glocker; Nikos Paragios; Nassir Navab; Vladlena Gorbunova; Jon Sporring; Marleen de Bruijne; Xiao Han; Mattias P Heinrich; Julia A Schnabel; Mark Jenkinson; Cristian Lorenz; Marc Modat; Jamie R McClelland; Sébastien Ourselin; Sascha E A Muenzing; Max A Viergever; Dante De Nigris; D Louis Collins; Tal Arbel; Marta Peroni; Rui Li; Gregory C Sharp; Alexander Schmidt-Richberg; Jan Ehrhardt; René Werner; Dirk Smeets; Dirk Loeckx; Gang Song; Nicholas Tustison; Brian Avants; James C Gee; Marius Staring; Stefan Klein; Berend C Stoel; Martin Urschler; Manuel Werlberger; Jef Vandemeulebroucke; Simon Rit; David Sarrut; Josien P W Pluim Journal: IEEE Trans Med Imaging Date: 2011-05-31 Impact factor: 10.048
Authors: Lindsay Mathew; Andrew Wheatley; Richard Castillo; Edward Castillo; George Rodrigues; Thomas Guerrero; Grace Parraga Journal: Acad Radiol Date: 2012-09-19 Impact factor: 3.173
Authors: Michael S Hofman; Jean-Mathieu Beauregard; Thomas W Barber; Oliver C Neels; Peter Eu; Rodney J Hicks Journal: J Nucl Med Date: 2011-09-09 Impact factor: 10.057
Authors: Tokihiro Yamamoto; Sven Kabus; Tobias Klinder; Jens von Berg; Cristian Lorenz; Billy W Loo; Paul J Keall Journal: Med Phys Date: 2011-03 Impact factor: 4.071
Authors: Yevgeniy Vinogradskiy; Richard Castillo; Edward Castillo; Leah Schubert; Bernard L Jones; Austin Faught; Laurie E Gaspar; Jennifer Kwak; Daniel W Bowles; Timothy Waxweiler; Jingjing M Dougherty; Dexiang Gao; Craig Stevens; Moyed Miften; Brian Kavanagh; Inga Grills; Chad G Rusthoven; Thomas Guerrero Journal: Int J Radiat Oncol Biol Phys Date: 2021-11-09 Impact factor: 7.038
Authors: Daniel A Low; Dylan O'Connell; Michael Lauria; Bradley Stiehl; Louise Naumann; Percy Lee; John Hegde; Igor Barjaktarevic; Jonathan Goldin; Anand Santhanam Journal: Med Phys Date: 2021-09-04 Impact factor: 4.506
Authors: Farnoush Forghani; Taylor Patton; Jennifer Kwak; David Thomas; Quentin Diot; Chad Rusthoven; Richard Castillo; Edward Castillo; Inga Grills; Thomas Guerrero; Moyed Miften; Yevgeniy Vinogradskiy Journal: Radiother Oncol Date: 2021-05-06 Impact factor: 6.901
Authors: Esther M Vicente; Arezoo Modiri; John Kipritidis; Kun-Chang Yu; Kai Sun; Jochen Cammin; Arun Gopal; Jingzhu Xu; Sina Mossahebi; Aaron Hagan; Yulong Yan; Daniel Rockwell Owen; Pranshu Mohindra; Martha M Matuszak; Robert D Timmerman; Amit Sawant Journal: Int J Radiat Oncol Biol Phys Date: 2022-03-09 Impact factor: 8.013
Authors: Leith J Rankine; Ziyi Wang; Chris R Kelsey; Elianna Bier; Bastiaan Driehuys; Lawrence B Marks; Shiva K Das Journal: Int J Radiat Oncol Biol Phys Date: 2021-07-13 Impact factor: 7.038
Authors: Wei Shao; Yue Pan; Oguz C Durumeric; Joseph M Reinhardt; John E Bayouth; Mirabela Rusu; Gary E Christensen Journal: Med Image Anal Date: 2021-06-21 Impact factor: 13.828